Showing results (141-150 of 229) with videos related to
Sort By:
Pageof 23
Nature Communications|June 25, 2014
Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patientsAnders Boeck Jensen, Pope L Moseley, Tudor I Oprea, et al.Assay and Drug Development Technologies|January 22, 2008
High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transportersIrena Ivnitski-Steele, Richard S Larson, Debbie M Lovato, et al.Plos Biology|December 12, 2018
Far away from the lamppostTudor I Oprea, Lily Jan, Gary L Johnson, et al.Journal of Chemical Information and Modeling|August 5, 2008
Efficient calculation of molecular properties from simulation using kernel molecular dynamicsW Michael Brown, Ariella Sasson, Donald R Bellew, et al.Bioinformatics (Oxford, England)|June 4, 2021
TIGA: target illumination GWAS analyticsJeremy J Yang, Dhouha Grissa, Christophe G Lambert, et al.Cancer Research|February 20, 2007
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cellsLidia Albanito, Antonio Madeo, Rosamaria Lappano, et al.Assay and Drug Development Technologies|September 17, 2009
Conformational mAb as a tool for integrin ligand discoveryBen H Njus, Alexandre Chigaev, Anna Waller, et al.Chemical Research in Toxicology|December 1, 1996
Ligand-based identification of environmental estrogensC L Waller, T I Oprea, K Chae, et al.Expert Opinion on Drug Discovery|March 16, 2013
High-throughput flow cytometry for drug discoveryBruce S Edwards, Susan M Young, Matthew J Saunders, et al.Nucleic Acids Research|December 9, 2022
DrugCentral 2023 extends human clinical data and integrates veterinary drugsSorin Avram, Thomas B Wilson, Ramona Curpan, et al.Pageof 23